Authors:
Jacobs, A
Tjuvajev, JG
Dubrovin, M
Akhurst, T
Balatoni, J
Beattie, B
Joshi, R
Finn, R
Larson, SM
Herrlinger, U
Pechan, PA
Chiocca, EA
Breakefield, XO
Blasberg, RG
Citation: A. Jacobs et al., Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo, CANCER RES, 61(7), 2001, pp. 2983-2995
Authors:
Vlassenko, AG
Thiessen, B
Beattie, BJ
Malkin, MG
Blasberg, RG
Citation: Ag. Vlassenko et al., Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI, J NEURO-ONC, 46(3), 2000, pp. 249-259
Authors:
Blasberg, RG
Roelcke, U
Weinreich, R
Beattie, B
von Ammon, K
Yonekawa, Y
Landolt, H
Guenther, I
Crompton, NEA
Vontobel, P
Missimer, J
Maguire, RP
Koziorowski, J
Knust, EJ
Finn, RD
Leenders, KL
Citation: Rg. Blasberg et al., Imaging brain tumor proliferative activity with [I-124]iododeoxyuridine, CANCER RES, 60(3), 2000, pp. 624-635
Citation: Rg. Blasberg et Jg. Tjuvajev, Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy, Q J NUCL M, 43(2), 1999, pp. 163-169
Authors:
Stegman, LD
Rehemtulla, A
Beattie, B
Kievit, E
Lawrence, TS
Blasberg, RG
Tjuvajev, JG
Ross, BD
Citation: Ld. Stegman et al., Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy, P NAS US, 96(17), 1999, pp. 9821-9826
Authors:
Tjuvajev, JG
Chen, SH
Joshi, A
Joshi, R
Guo, ZS
Balatoni, J
Ballon, D
Koutcher, J
Finn, R
Woo, SL
Blasberg, RG
Citation: Jg. Tjuvajev et al., Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo, CANCER RES, 59(20), 1999, pp. 5186-5193